Galderma Laboratories has received Food and Drug Administration approval for antibiotic-free Epiduo Forte Gel (adapalene and benzoyl peroxide 0.3%/2.5%), a once-daily topical acne treatment. Galderma said Thursday Epiduo Forte Gel is the first combination of 0.3%/2.
launched in late June by the Canadian Pharmacists Association (CPhA) — aims to build a national consensus for a pan-Canadian pharmacare framework. CPhA noted that all developed countries with universal health care, except Canada, provide universal coverage for
Cardinal Health Inc. plans to acquire medication therapy management specialist OutcomesMTM. Financial terms of the transaction weren’t disclosed.
The retail health clinic market is seeing competition intensify as the leading players expand their reach with new locations. Market leader MinuteClinic, part of CVS Health, got a big boost last month with CVS’ $1.9 billion deal to buy the pharmacy and clinic business of Target Corp.
Jeff Berkowitz, executive vice president at Walgreens Boots Alliance and president of Pharma and Global Market Access, has left the company.
Community pharmacies that used scan-verification and counting technology prevented an average of 2.7 potential prescription errors per week, according to a national study by Kirby Lester.
The National Community Pharmacists Association has called on Congress, Medicare and industry stakeholders to strike a balance in stamping out fraud in Medicare Part D while preserving patient access to critical medications.
A survey by the Asthma and Allergy Foundation of America (AAFA) has revealed consumer concerns about access to over-the-counter cold/cough and allergy medicines containing pseudoephedrine (PSE).
Aurobindo Pharma Ltd. has received final approval from the U.S. Food and Drug Administration for flecainide acetate tablets, a medication for irregular heartbeat.
Shoppers Drug Mart has teamed up with the Partnership for a Drug-Free Canada (PDFC) for a National Medicine Take-Back Campaign that will run from July to December.
The U.S. House of Representatives has passed the 21st Century Cures Act (H.R. 6), which the National Association of Chain Drug Stores said will speed the pace of cures and medical breakthroughs and position pharmacy to play a pivotal role in the delivery of new drug treatments to patients.
Novartis has received Food and Drug Administration approval for Entresto (sacubitril/valsartan) tablets, a medication for heart failure with reduced injection fraction. An angiotensin receptor neprilysin inhibitor (ARNI), Entresto reduces the strain on a failing heart.
Walgreens, CVS/Pharmacy, Rite Aid and Walmart among them — receive a great deal of attention. Similarly, regional chains including Wegmans, H-E-B, Publix and Schnucks are examples of a force in their respective markets.
Eleven congressmen have asked the Centers for Medicare & Medicaid Services (CMS) for information on the enforcement of transparency measures for generic drug payments in Medicare Part D plans for 2016. The National Community Pharmacists Association said Thursday that this week U.S. Reps.
Cardinal Health Inc. is providing more than $1 million in funding to 10 pharmacy schools across the country as part of its efforts to support future pharmacists.
The approval of Vertex Pharmaceuticals Inc.’s Orkambi (lumacaftor/ivacaftor) is being hailed as a big stride forward in the treatment of cystic fibrosis. The Food and Drug Administration announced its approval of the drug just before the holiday weekend.
